TOKYO -- Japanese beverage maker Kirin Holdings will start supplying Southeast Asian nations with a postbiotic that has been shown to treat symptoms of dengue fever, the company said Friday.
Kirin will start selling a product called LC-Plasma, a proprietary functional ingredient found in the company's health drinks. Kirin will sell the postbiotic to food and drink makers in the region.
